Trials / Sponsors / Tragara Pharmaceuticals, Inc.
Tragara Pharmaceuticals, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | 2012-09-01 |
| Completed | Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies AML, ALL, Blast Crisis | Phase 1 | 2010-08-01 |
| Completed | APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | 2008-08-01 |
| Terminated | APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2 Breast Cancer | Phase 2 | 2008-04-01 |
| Completed | APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell L Recurrent Non Small Cell Lung Cancer | Phase 2 | 2008-04-01 |
| Completed | Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients Non-small Cell Lung Cancer | Phase 1 | 2007-10-01 |